Oral News and Research

RSS

Affordable Care Act falls well short in improving health outcomes, reveals new ADA analysis

When it comes to access to routine dental care – a major determinant of oral health – the Affordable Care Act falls well short in its goals of lowering costs, increasing access and improving health outcomes, according to new analysis by the American Dental Association.

10 May 2013

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase Deficiency.

9 May 2013

Strax Rejuvenation reaches impressive milestone

Strax Rejuvenation, a plastic surgery and wellness center based in Florida, has just reached an impressive milestone: there have been over 40,000 patients who have had procedures performed by staff surgeons at various surgery facilities over the past seven years.

9 May 2013

PCORI awards $2M to UNC med school for diabetes research

The Patient-Centered Outcomes Research Institute has approved a research award to the University of North Carolina School of Medicine to study the role of glucose monitoring in patients with type 2 diabetes using oral medications.

9 May 2013

Nearly 5 million asthmatics with ABPA could benefit from antifungal treatment, say researchers

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.

9 May 2013

Patients with ASPS appear to benefit from anti-cancer drug, cediranib

Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib.

8 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Study investigates use of sublingual immunotherapy against ragweed allergy

An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal congestion and itchy eyes experienced by ragweed allergy sufferers.

8 May 2013

Swedish researchers report simple habit to protect against allergy development in children

Allergies are very common in industrialized countries. It has been suggested that exposure to harmless bacteria during infancy may be protective against the development of allergy. However, it has been difficult to pinpoint which bacteria a baby should be exposed to, and at what time and by which route this exposure should ideally occur.

8 May 2013

Clinical data of cabozantinib to be presented at ASCO meeting

Exelixis, Inc. announced today that cabozantinib will be the subject of nine separate data presentations at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology.

8 May 2013

Janssen enrolls patients in expanded access program for mantle cell lymphoma

Janssen Research & Development, LLC (Janssen) today announced patients are now enrolling in a multicenter, open-label expanded access program (EAP) in the United States for the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib, which is being jointly developed by Janssen and Pharmacyclics, Inc.

7 May 2013

ECMO can be used on neonates with severe respiratory failure until lung transplantation, say scientists

Adults with end-stage respiratory failure and pulmonary hypertension requiring ECMO (extracorporeal membrane oxygenation) have been "bridged" toward lung transplantation with novel lung assist devices such as the Novalung.

7 May 2013

Perrigo net sales increase 18% to $920M in third quarter 2013

Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted diluted earnings per share.

7 May 2013

Biocryst reports financial results for first quarter 2013

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2013.

7 May 2013

800 IU of vitamin D3 per day is recommended for preterm infants, says study

Preterm infants may need to be given 800 international units (IU) of vitamin D a day to ensure they develop strong bones, according to a study to be presented Sunday, May 5, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.

6 May 2013

Oral drops provide a safe and effective alternative for allergy sufferers

Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial - and stick-free - option for pediatric allergy sufferers, according to a Johns Hopkins Children's Center review of existing scientific evidence.

6 May 2013

New position paper shows strong connection between nutrition and oral health

There is a strong connection between the food people eat and their oral health, according to a recently updated position paper of the Academy of Nutrition and Dietetics.

5 May 2013

Research roundup: Surgical care at critical access hospitals; Digging into the cost of emergency medicine; Getting what you want for end-of-life care

During the past 15 years, the number of critical access hospitals – those with fewer than 25 acute care beds that receive higher reimbursements and other considerations from Medicare to help sustain them – has increased substantially, representing a quarter of all U.S. acute care hospitals in 2011.

4 May 2013

Girls with learning, physical disabilities more likely to suffer menstrual problems

New research shows girls with learning and physical disabilities are more likely to suffer period problems compared to the general population.

3 May 2013

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.

3 May 2013

Oral News and Research

Affordable Care Act falls well short in improving health outcomes, reveals new ADA analysis

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Strax Rejuvenation reaches impressive milestone

PCORI awards $2M to UNC med school for diabetes research

Nearly 5 million asthmatics with ABPA could benefit from antifungal treatment, say researchers

Patients with ASPS appear to benefit from anti-cancer drug, cediranib

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Study investigates use of sublingual immunotherapy against ragweed allergy

Swedish researchers report simple habit to protect against allergy development in children

Clinical data of cabozantinib to be presented at ASCO meeting

Janssen enrolls patients in expanded access program for mantle cell lymphoma

ECMO can be used on neonates with severe respiratory failure until lung transplantation, say scientists

Perrigo net sales increase 18% to $920M in third quarter 2013

Biocryst reports financial results for first quarter 2013

800 IU of vitamin D3 per day is recommended for preterm infants, says study

Oral drops provide a safe and effective alternative for allergy sufferers

New position paper shows strong connection between nutrition and oral health

Research roundup: Surgical care at critical access hospitals; Digging into the cost of emergency medicine; Getting what you want for end-of-life care

Girls with learning, physical disabilities more likely to suffer menstrual problems

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News